Immediate Impact
5 standout
Citing Papers
Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update
2025 Standout
The clinical landscape of CAR NK cells
2025 Standout
Works of Swathi Namburi being referenced
Interim results from the ELiPSE-1 study: A phase 1, multicenter, open-label study of CNTY-101 in subjects with relapsed or refractory CD19-positive B-cell malignancies.
2024
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Swathi Namburi | 12 | 5 | 27 | 11 | 6 | 38 | |
| Yoshihito Horisawa | 10 | 6 | 28 | 12 | 9 | 42 | |
| Abderezak Zebboudj | 21 | 2 | 22 | 13 | 5 | 55 | |
| Jing Lv | 6 | 3 | 14 | 5 | 7 | 36 | |
| Marwa H. Elnagdy | 8 | 1 | 25 | 17 | 7 | 47 | |
| Isabella Y. Kong | 20 | 22 | 24 | 9 | 7 | 53 | |
| Robbie Jin | 11 | 22 | 9 | 6 | 48 | ||
| Yamini Ogoti | 10 | 22 | 17 | 5 | 6 | 34 | |
| Hoang Nguyen | 7 | 2 | 34 | 3 | 5 | 53 | |
| Xuanxuan Zou | 4 | 25 | 12 | 8 | 51 | ||
| Tim Forgan | 21 | 25 | 6 | 5 | 62 |
All Works
Loading papers...